Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein

Journal of Hepatology

Volumn 30, Issue 4, 1999, Pages 660-668

  Yamakado, Koichiro ^a   Tanaka, Naoshi ^a   Nakatsuka, Atsuhiro ^a   Matsumura, Kaname ^a   Takase, Kojiro ^a   Takeda, Kan ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Expandable metallic stent; Hepatocellular carcinoma; Portal vein; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; DISEASE ASSOCIATION; ECHOGRAPHY; ESOPHAGUS VARICES; FALSE ANEURYSM; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; MELENA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; SCLEROTHERAPY; STENT; SURVIVAL RATE; VEIN PUNCTURE;

EID: 0033053969     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80197-4     Document Type: Article

References (24)

1. The Liver Cancer Study Group of Japan . Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg. 21:1990;277-287.
2. Kumagai M. Clinical evaluation of tumor invasion in the portal vein demonstrated by angiography in patients with hepatocellular carcinoma. Kanzou. 26:1985;1514-1521.
3. Okada S., Okazaki N., Nose H., Yoshimori M., Aoki K. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology. 16:1992;112-117.
4. Raoul J.L., Guyader D., Bretagne J.F., Duvauferrier R., Bourguet P., Bekhechi D., et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med. 35:1994;1782-1787.
5. Imaeda T., Sone Y., Yamawaki Y., Seki M., Goto H. Liver hypertrophy in association with tumor thrombus in the portal vein: CT findings. JCAT. 15:1991;542-549.
6. Yamashita Y., Takahashi M., Koga Y., Saito R., Nanakawa S., Hatanaka Y., et al. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer. 67:1991;385-391.
7. Yamanaka N., Okamoto E., Toyosaka A., Mitunobu M., Fujihara S., Kato T., et al. Prognostic factors after hepatectomy for hepatocellular carcinomas: a univariate and multivariate analysis. Cancer. 65:1990;1104-1110.
8. Shirakabe K., Kanematsu T., Matsuhata T., Adachi E., Akazawa K., Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analysis. Hepatology. 14:1991;802-805.
9. Lo G.H., Lin C.Y., Lai K.H., Malik U., Ng W.W., Lee F.Y., et al. Endoscopic injection sclerotherapy versus conservative treatment for patients with unresectable hepatocellular carcinoma and bleeding esophageal varices. Gastrointest Endosc. 37:1991;161-164.
10. Cottone M., Marceno M.P., Maringhini A., Rinaldi F., Russo G., Sciarrino E., et al. Ultrasound in the diagnosis of hepatocellular carcinoma associated with cirrhosis. Radiology. 147:1983;517-519.
11. Itai Y., Nishikawa J., Tasaka A. Computed tomography in the evaluation of hepatocellular carcinoma. Radiology. 131:1979;165-170.
12. Takayasu K., Shima Y., Muramatsu Y., Goto H., Moriyama N., Yamada T., et al. Angiography of small hepatocellular carcinomas: analysis of 105 resected tumors. AJR. 147:1986;525-529.
13. Schnall M. Magnetic resonance imaging of focal liver lesions. Semin Roentgenol. 30:1995;347-361.
14. Okuda K., Ohtsuki T., Obata H., Tomimatsu M., Okazaki N., Hasagawa H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer. 56:1985;918-928.
15. Pugh R.N.H., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-649.
16. Chung J.W., Park J.H., Han J.K., Choi B.I., Han M.C. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. AJR. 165:1995;315-321.
17. Ohnishi K., Okuda K., Ohtsuki T., Nakayama T., Hiyama Y., Iwama S., et al. Formation of hilar collaterals or cavernous transformation after portal vein obstruction by hepatocellular carcinoma. Observation in ten patients. Gastroenterology. 87:1984;1150-1153.
18. Hara H., Okazaki M., Ono Y., Nakamura T., Oda Z. A long surviving hepatocellular carcinoma case (2 years 1 month) with tumor thrombus in the portal trunk treated by embolization. Jpn J Clin Radiol. 34:1989;1641-1644.
19. Rossi P., Bezzi M., Rossi M., Adam A., Chetty N., Roddie M.E., et al. Metallic stents in malignant biliary obstruction: results of a multicenter European study of 240 patients. JVIR. 5:1994;279-285.
20. Kishi K., Mitsuzane K., Sonomura T., Nishida N., Sato M., Yamada R. Dacron-covered stent therapy for portal vein tumor thrombus in hepatocellular carcinoma. Acta Radiol. 3:1993;266-269.
21. Noeldge G., Richter G.M., Sieferstetter V., Garcia O., Palmatz J.C. Tierexperimentelle Untersuchungen bei den Einfluss der Flussrestriktion auf die Thrombogenität des Palmatz-Stent mittels 111-Indium-markierter Thrombozyten. RÖFO. 152:1990;264-268.
22. Siegerstetter V., Krause T., Rossle M., Haag K., Ochs A., Hauenstein K.H., et al. Transjugular intrahepatic portosystemic shunt (TIPS). Thrombogenicity in stents and its effect on shunt patency. Acta Radiol. 38:1997;664-668.
23. Fischman D.L., Leon M.B., Baim D.S., Shatz R.A., Savage M.P., Penn I., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 331:1994;496-501.
24. Moussa I., Mario C.D., Francesco L.D., Reimers B., Blengino S., Colombo A. Subacute stent thrombosis and the anticoagulation controversy: changes in drug therapy, operator technique, and the impact of intravascular ultrasound. Am J Cardiol. 78:(suppl 3A):1996;13-17.